AFYREN

Afyren Neoxy Gets €3.4 Million in After-Biochem Project

Greentech firm Afyren Neoxy, a subsidiary of Afyren, received a €3.4 million payment this week for achieving key milestones with its bio-based low-carbon products.

News

Afyren Sites Second Organic Acids Plant in Thailand

French greentech firm Afyren will build a second bio-based organic acids plant, this time in Thailand, adding to a first facility in France. Marking its first international project, the new plant will be undertaken in partnership with Mitr Phol, which regards itself as the world’s third-largest sugar producer.

News

Afyren Increases Equity to Fund First Pant

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

AFYREN SAS